Familial Hypercholesterolemia Latest Advances

Genetic Cascade Screening for Familial Hypercholesterolemia: A Randomized Clinical Trial.

Journal: JAMA network open

Published: April 13, 2026

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy.

Journal: Journal of atherosclerosis and thrombosis

Published: March 29, 2026

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia.

Journal: Journal of atherosclerosis and thrombosis

Published: March 29, 2026

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

Journal: JAMA

Published: March 25, 2026

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

Journal: JAMA

Published: March 25, 2026

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood-Reply.

Journal: JAMA

Published: March 25, 2026

Genetic dyslipidemias.

Journal: Annales d'endocrinologie

Published: March 22, 2026

The safety and efficacy of adeno-associated virus-mediated LDLR transfection in homozygous familial hypercholesterolemia

Journal: Zhonghua xin xue guan bing za zhi

Published: March 22, 2026

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 22, 2026

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Journal: Circulation

Published: March 13, 2026

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Journal: Journal of the American College of Cardiology

Published: March 13, 2026

Lipoprotein(a) levels in children and adolescents: a systematic review and meta-analysis of associations with parental cardiovascular disease, familial hypercholesterolemia, and gender differences.

Journal: Postgraduate medicine

Published: March 12, 2026

Familial Hypercholesterolemia Latest Advances

Find the Latest Research About Familial Hypercholesterolemia

Genetic Cascade Screening for Familial Hypercholesterolemia: A Randomized Clinical Trial.

Genetic Cascade Screening for Familial Hypercholesterolemia: A Randomized Clinical Trial.

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy.

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy.

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia.

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia.

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood-Reply.

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood-Reply.

Genetic dyslipidemias.

Genetic dyslipidemias.

The safety and efficacy of adeno-associated virus-mediated LDLR transfection in homozygous familial hypercholesterolemia

The safety and efficacy of adeno-associated virus-mediated LDLR transfection in homozygous familial hypercholesterolemia

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events - The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events - The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Lipoprotein(a) levels in children and adolescents: a systematic review and meta-analysis of associations with parental cardiovascular disease, familial hypercholesterolemia, and gender differences.

Lipoprotein(a) levels in children and adolescents: a systematic review and meta-analysis of associations with parental cardiovascular disease, familial hypercholesterolemia, and gender differences.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.